Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

API Manufacturing: SOP for Destruction of Used IPC Samples – V 2.0

Posted on By

API Manufacturing: SOP for Destruction of Used IPC Samples – V 2.0

Standard Operating Procedure for Destruction of Used IPC Samples in API Manufacturing

Department API Manufacturing
SOP No. SOP/API/106/2025
Supersedes SOP/API/106/2022
Page No. Page 1 of 10
Issue Date 13/04/2025
Effective Date 15/04/2025
Review Date 13/04/2026

1. Purpose

To define the procedure for safe, compliant, and documented destruction of In-Process Control (IPC) samples after testing and analysis are complete, ensuring traceability and adherence to regulatory requirements.

2. Scope

This SOP applies to all IPC samples (solid, semi-solid, liquid) collected and tested during API manufacturing processes and retained temporarily within QC labs or IPC stations.

3. Responsibilities

  • QC Analyst: Identify and segregate used IPC samples, initiate destruction procedure, and record entries.
  • QA Officer: Review destruction records and approve the destruction log before disposal.
  • Production Chemist: Provide traceability reference (batch number, stage, sample type) to QC as needed.
See also  API Manufacturing: SOP for Recrystallization for API Purification - V 2.0

4. Accountability

The QC Head is accountable for execution of destruction, while the QA Head is responsible for approval and oversight of sample destruction in accordance with GMP practices.

5. Procedure

5.1 Identification of Used IPC Samples

  1. Upon completion of testing, segregate samples marked as “Used” or “Tested” and ready for disposal.
  2. Ensure samples are no longer required for re-analysis, investigation, or training purposes.
  3. Check if hold samples or retention samples are separate and not impacted by the destruction batch.

5.2 Documentation Prior to Destruction

  1. Record details of used samples in the IPC Sample Destruction Logbook (Annexure-1).
  2. Each entry should include:
    • Batch Number
    • Stage of Sampling
    • Sample Quantity
    • Date of Destruction
    • Reason for Destruction
  3. QA shall verify and sign off before physical disposal of the sample.

5.3 Destruction Methods

  1. Use the following destruction methods based on sample type:
    • Solid and Powdered Samples: Mix with inert absorbent material and dispose in non-recoverable containers, marked as pharmaceutical waste.
    • Liquid Samples: Neutralize if reactive, absorb into disposal granules or dispose through waste solvent drain as per SOP.
    • Semi-solid Samples: Absorb using disposal tissue/pads and discard as per solid waste disposal SOP.
  2. All destroyed samples must be rendered non-recoverable and unidentifiable.
See also  API Manufacturing: SOP for Intermediate Moisture Check using IR Balance - V 2.0

5.4 Disposal Coordination

  1. Disposed samples shall be transferred to the designated Waste Collection Area.
  2. Coordinate with EHS (Environment, Health & Safety) team or disposal vendor (if applicable) as per waste disposal SOP.
  3. Maintain records of batch disposal along with sample disposal forms, signed by QC and QA.

5.5 Special Situations

  1. For samples associated with OOS or Deviations, retain them until the investigation is closed.
  2. Destruction for such samples must be reviewed with QA and investigation number should be referenced.

6. Abbreviations

  • SOP: Standard Operating Procedure
  • IPC: In-Process Control
  • QC: Quality Control
  • QA: Quality Assurance
  • OOS: Out of Specification
  • EHS: Environment, Health & Safety
See also  API Manufacturing: SOP for Particle Size Distribution Monitoring - V 2.0

7. Documents

  1. IPC Sample Destruction Logbook (Annexure-1)
  2. Waste Disposal Record (As per Waste Management SOP)
  3. Investigation Closure Summary (if applicable)

8. References

  • ICH Q7 – GMP Guide for Active Pharmaceutical Ingredients
  • 21 CFR Part 211 – US FDA cGMP
  • WHO TRS 986 – GMP Guidelines
  • Company SOP on Waste Disposal

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: IPC Sample Destruction Logbook

Date Batch No. Stage Sample Qty Destroyed By Verified By (QA) Remarks
13/04/2025 API-20250413 Drying 10 g Ravi Kumar QA Officer Complies

Revision History:

Revision Date Revision No. Details Reason Approved By
01/01/2022 1.0 Initial SOP Release Compliance QA Head
13/04/2025 2.0 Added coordination with EHS and expanded destruction methods Audit Compliance QA Head
API Manufacturing V 2.0 Tags:API batch record, API BMR, API calibration, API centrifuge, API cleaning, API crystallization, API deviation, API documentation, API drying, API equipment cleaning, API filtration, API GMP compliance, API granulation, API hold time, API impurities, API line clearance, API manufacturing, API process, API quality control, API reactor, API sampling, API solvent handling, API validation, API waste disposal, API yield

Post navigation

Previous Post: Analytical Method Development: Colorimetric Method Development – V 2.0
Next Post: BA-BE Studies: SOP for Maintaining Source Data Verification Logs – V 2.0

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version